ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

AMA Supports Right To Silicone Implants, Kessler Takes Issues

December 3, 1993

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993